Urticaria causes and treatment
Pro Research Analysisby 
Searched over 200M research papers
Urticaria Causes: Triggers and Underlying Mechanisms
Urticaria, commonly known as hives, is a frequent skin disorder affecting up to 20% of people at some point in their lives. It presents as itchy, red, and swollen plaques or wheals, sometimes accompanied by deeper swelling called angioedema. The main cause is the release of histamine and other inflammatory mediators from mast cells and basophils, which can be triggered by both immunoglobulin E (IgE)-mediated and non-IgE-mediated mechanisms Schaefer2017Gheyasuddin2022Kolkhir2022.
Acute urticaria often results from infections, medications, foods, or respiratory allergens. Chronic urticaria, which lasts more than six weeks, is classified as either chronic spontaneous urticaria (CSU) or chronic inducible urticaria (CIndU). CSU occurs without a clear trigger, while CIndU has specific triggers like cold, pressure, or other physical factors He2021Kayıran2019Kolkhir2022. In 80–90% of chronic urticaria cases, the cause remains unknown (idiopathic), but possible underlying factors include autoimmunity, infections, coagulation abnormalities, and vitamin D deficiency Schaefer2017He2021Kolkhir2022.
Diagnosis of Urticaria: Clinical Approach
Diagnosis of urticaria is primarily clinical, based on the appearance of transient, itchy wheals and/or angioedema. It is important to rule out anaphylaxis, which is a medical emergency. In chronic cases, a limited laboratory workup may be considered if the history or physical exam suggests an underlying condition. Differential diagnoses include urticarial vasculitis, drug eruptions, and viral rashes Schaefer2017Gheyasuddin2022Kayıran2019+1 MORE.
Urticaria Treatment: Stepwise and Targeted Approaches
First-Line and Standard Therapies
The mainstay of urticaria treatment is avoidance of known triggers, if identified. The first-line pharmacological treatment is second-generation H1 antihistamines, which are preferred due to their safety and effectiveness. The dose can be increased up to four times the standard amount if symptoms persist Schaefer2017Gheyasuddin2022Kayıran2019+4 MORE.
Adjunct and Advanced Therapies
If symptoms are not controlled with antihistamines, additional options include:
- Short-term systemic corticosteroids for severe flares
- H2 antihistamines and leukotriene receptor antagonists as adjuncts
- Omalizumab (an anti-IgE monoclonal antibody) for chronic cases unresponsive to antihistamines
- Cyclosporine or other immunosuppressive agents for refractory cases Schaefer2017Gheyasuddin2022Kayıran2019+5 MORE
Emerging and Personalized Treatments
For patients who do not respond to standard therapies, new treatments are being developed. These include Bruton’s tyrosine kinase inhibitors (e.g., remibrutinib), drugs targeting interleukin-4 and interleukin-13 pathways (e.g., dupilumab), and agents that block mast cell activation through other mechanisms. Personalized treatment approaches based on the patient’s specific disease subtype and underlying mechanisms are becoming more important, especially for chronic urticaria He2021Kolkhir2022Zuberbier2024+1 MORE.
Alternative and Integrative Approaches
Some traditional and alternative medicine systems, such as Unani and homeopathy, offer their own frameworks and remedies for urticaria. However, these approaches are less well-studied and are generally considered complementary to standard medical care Gheyasuddin2022Malviya2024.
Conclusion
Urticaria is a common and often distressing skin condition with a variety of causes, most commonly related to mast cell activation and histamine release. Diagnosis is clinical, and treatment follows a stepwise approach starting with second-generation H1 antihistamines and escalating to advanced therapies for resistant cases. Ongoing research is expanding treatment options, especially for chronic and difficult-to-treat urticaria, with a focus on targeted and personalized therapies. Most patients experience significant improvement or resolution of symptoms within a year, but persistent cases may require specialist care and novel interventions Schaefer2017He2021Kolkhir2022+2 MORE.
Sources and full results
Most relevant research papers on this topic